Effect of Fenofibrate on the Concentration and Relative Distribution of LDL Subfractions in Patients with Combined Dyslipidemia

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|1|4|380-383

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.1, Iss.4, 2004-10, pp. : 380-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3858-3868

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of fenofibrate on LDL-induced endothelial dysfunction in rats

By Yang Tian-Lun   Chen Mei-Fang   Luo Bai-Ling   Yu Jing   Jiang Jun-Lin   Li Yuan-Jian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 79-83

Springer Publishing Company

Access to resources Recommend Favorite

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

By Agouridis Aris P   Tsimihodimos Vasilis   Filippatos Theodosios D   Dimitriou Andromachi A   Tellis Costantinos C   Elisaf Moses S   Mikhailidis Dimitri P   Tselepis Alexandros D  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2605-2611

Informa Healthcare

Access to resources Recommend Favorite

LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options

By  

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6249-6255

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Disease and Dyslipidemia: Beyond LDL

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 861-870

Bentham Science Publishers

Access to resources Recommend Favorite